ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial

BACKGROUND: Sepsis is a major challenge in critical care and is associated with high mortality. Current management of sepsis and septic shock remains mainly supportive. Both basic and clinical research has shown that ulinastatin can improve the prognosis of sepsis. The aim of this trial is to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wei, Yu, Xiangyou, Sun, Tongwen, Chai, Yanfen, Chang, Ping, Chen, Zhongqing, Pan, Jingye, Peng, Zhiyong, Wang, Ruilan, Wang, Xiaozhi, Xu, Yuan, Yu, Li, Zheng, Qingshan, Du, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822617/
https://www.ncbi.nlm.nih.gov/pubmed/29467017
http://dx.doi.org/10.1186/s13063-018-2513-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822617/
https://www.ncbi.nlm.nih.gov/pubmed/29467017
http://dx.doi.org/10.1186/s13063-018-2513-y

Ejemplares similares